Clinical Trial Update: Xenogenous Collagen Matrix Graft With or Without Enamel Matrix Proteins Derivative for Root Coverage [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluated a xenogenous collagen matrix graft with or without enamel matrix derivative for root coverage in gingival recession; the study status …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gingival Recession

Drugs mentioned

• Emdogain (Enamel Matrix Derivative)
• Xenogenous collagen matrix graft

Snippet

Sponsor: University of Campinas, Brazil | Conditions: Gingival Recession | Phase 4 | Status: COMPLETED